Lung Disease Clinical Trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 3361 clinical trials
Featured trial
NO 0050-0637

ICON Early Phase Services is conducting a non-interventional device research study adults age 40+ who are either healthy, or, have chronic obstructive pulmonary disease (COPD). This study is being

  • 613 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Add on treatment for COPD for patients who experience frequent exacerbations

Current or former smokers who are diagnosed with COPD and experienced at least 2 exacerbations- worsening of symptoms requiring steroid treatment or hospitalization despite being on multiple inhaler medications may qualify for this study involving benralizumab subcutaneous injections compared to placebo injections, initially every 4 weeks, then every 8 weeks …

  • 0 views
  • 09 Jun, 2022
  • 1 location
Featured trial
DO YOU HAVE COPD?

You may be eligible to participate in a research study of an investigational new medication. 

  • 0 views
  • 29 Jun, 2022
  • 1 location
Featured trial
Phase 3 Study of MRTX849 vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-12)

This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 versus docetaxel in patients who have been previously treated for metastatic NSCLC with a KRAS G12C mutation.

lung cancer
advanced lung cancer
docetaxel
KRAS
lung metastases
  • 37 views
  • 27 Dec, 2022
  • 202 locations
Featured trial
A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy (SAPPHIRE)

This is an open-label, randomized (1:1), multicenter, Phase 3 clinical trial evaluating the safety and efficacy of nivolumab in combination with investigational agent sitravatinib compared to docetaxel in patients with advanced non-squamous NSCLC who have previously experienced radiographic disease progression on or after treatment with platinum-based chemotherapy in combination with …

platinum-based chemotherapy
cancer
lung cancer
squamous non-small cell lung cancer
advanced non-squamous non-small cell lung cancer
  • 543 views
  • 04 May, 2022
  • 143 locations
Featured trial
Role of Genetic Factors in the Pathogenesis of Lung Disease

This study is designed to evaluate the genetics involved in the development of lung disease by surveying genes involved in the process of breathing and examining the genes in lung cells of

pulmonary disease
pulmonary fibrosis
bronchoscopy
diabetes
  • 358 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

  • 207 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

  • 150 views
  • 08 Nov, 2020
  • 1 location
Featured trial
COPD (Chronic Obstructive Pulmonary Disease)

COPD (Chronic Obstructive Pulmonary Disease)

  • 442 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Advanced Non-Small Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer

  • 138 views
  • 08 Nov, 2020
  • 1 location